Fu chengcheng PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse (NCT05559788) | Fu chengcheng PhD | 2022-09-20 |
Track Fu chengcheng PhD automatically
Every clearance here is in the API, with alerts when new ones post.